|
US 6255560 (NOTE: USPTO PAIR shows that this patent was allowed to lapse in 3/2005 by owner non-payment of fees. IT IS NO LONGER IN FORCE) |
|---|
| Claim 1
A chimeric gene which is expressed in plant cells comprising:
|
| Claim 3
A plant cell comprising a chimeric gene which comprises: a) a promoter from cauliflower mosaic virus (CaMV), wherein said promoter is the CaMV(19S) promoter or the CaMV(35S) promoter, operably linked to a DNA sequence which is heterologous with respect to the promoter, wherein:
|
| Claim 6
An intermediate plant transformation plasmid which comprises: a) a region of homology to an A. tumefaciens vector; |
| Claim 9
A plant transformation vector which comprises a modified plant tumor inducing
plasmid of A. tumefaciens which is capable of inserting a chimeric gene
into susceptible plant cells, wherein the chimeric gene comprises a promoter
from cauliflower mosaic virus (CaMV), wherein said promoter is the CaMV(19S)
promoter or the CaMV(35S) promoter, operably linked to a DNA sequence which is
heterologous with respect to the promoter, wherein: a) the promoter regulates
the transcription of the DNA sequence, and |
| Claim 12
A differentiated dicotyledonous plant comprising plant cells containing a
chimeric gene which comprises a promoter from cauliflower mosaic virus (CaMV),
wherein said promoter is the CaMV(19S) promoter or the CaMV(35S) promoter,
operably linked to a DNA sequence encoding said polypeptide which is
heterologous with respect to the promoter, wherein: a) the promoter regulates
the transcription of the DNA sequence, and |
The information contained in this page was believed to be correct at the time it was collated. New patents and patent applications, altered status of patents, and case law may have resulted in changes in the landscape. CAMBIA makes no warranty that it is correct or up to date at this time and accepts no liability for any use that might be made of it. Corrections or updates to the information are welcome. Please send an email to info@bios.net.



There are no comments.